Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

PainReform Ltd. (PRFX) vs China SXT Pharmaceuticals, Inc. (SXTC)

PainReform Ltd. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. China SXT Pharmaceuticals, Inc. is the larger, with a market value of $3.5M against $3.0M — 1.2× the size. PainReform Ltd. has the higher net margin (0.00% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, China SXT Pharmaceuticals, Inc. leads on 5 and PainReform Ltd. on 4.

Valuation

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B 0.00 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.99 2.66 12.29
EV/Sales n/m (5.94) 2.56
Earnings yield (61,696.04%) (4,331.13%) (2.99%)
Free cash flow yield (80,633.63%) 0.00% 0.00%

Profitability

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 36.69% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (255.16%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (53.98%) 10.01%
EPS growth (last fiscal year) 92.92% 97.36% —
Revenue growth, 5-year CAGR — (24.94%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.03 0.05
Current ratio 5.07 7.94 2.31
Net debt to EBITDA 0.96 3.86 0.85

Dividend

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Market cap 2.95m 3.49m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack